These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 10681720

  • 1. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression.
    Martín-Henao GA, Quiroga R, Sureda A, González JR, Moreno V, García J.
    Haematologica; 2000 Feb; 85(2):139-46. PubMed ID: 10681720
    [Abstract] [Full Text] [Related]

  • 2. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M, Lishner M, Amiel A, Nagler A, Yarkorli S, Rudi A, Kashman Y, Markel D, Fabian I.
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [Abstract] [Full Text] [Related]

  • 3. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
    Straetmans N, Ma DD, Nevell DF, Arthur C.
    Hematopathol Mol Hematol; 1996 Dec; 10(4):213-22. PubMed ID: 9042664
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Decreased L-selectin expression in CD34-positive cells from patients with chronic myelocytic leukaemia.
    Kawaishi K, Kimura A, Katoh O, Sasaki A, Oguma N, Ihara A, Satow Y.
    Br J Haematol; 1996 May; 93(2):367-74. PubMed ID: 8639430
    [Abstract] [Full Text] [Related]

  • 6. Initial expression of interferon alpha receptor 2 (IFNAR2) on CD34-positive cells and its down-regulation correlate with clinical response to interferon therapy in chronic myelogenous leukemia.
    Ito K, Tanaka H, Ito T, Sultana TA, Kyo T, Imanaka F, Ohmoto Y, Kimura A.
    Eur J Haematol; 2004 Sep; 73(3):191-205. PubMed ID: 15287917
    [Abstract] [Full Text] [Related]

  • 7. [Expression of beta 2 integrins and L-selectin on CML cells after treatment with IFN-alpha and allo-bone marrow transplantation].
    Tong X, Luo S, Hong W.
    Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):474-6. PubMed ID: 11235567
    [Abstract] [Full Text] [Related]

  • 8. Adenovirus and retrovirus mediated interferon alpha gene transfer into CD34+ cells maintains regeneration capacity and enhances adhesion molecules in K562 cells.
    Seiter K, Kancherla R, Yang L, Quan S, Farley TJ, Abraham NG, Ahmed T.
    J Investig Med; 1999 Sep; 47(8):414-24. PubMed ID: 10510594
    [Abstract] [Full Text] [Related]

  • 9. Characterization and selection of benign stem cells in chronic myeloid leukemia.
    Lemoli RM.
    Haematologica; 1993 Sep; 78(6):393-400. PubMed ID: 8175034
    [Abstract] [Full Text] [Related]

  • 10. Potent antileukemic activity of the novel agents norsegoline and dibezine.
    Einat M, Nagler A, Lishner M, Amiel A, Yarkoni S, Rudi A, Gellerman G, Kashman Y, Fabian I.
    Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cell adhesion molecule expression in cord blood CD34+ cells.
    Timeus F, Crescenzio N, Basso G, Ramenghi U, Saracco P, Gabutti V.
    Stem Cells; 1998 Aug; 16(2):120-6. PubMed ID: 9554036
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MA.
    Cancer Res; 2000 Feb 01; 60(3):610-7. PubMed ID: 10676644
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
    Primo D, Flores J, Quijano S, Sanchez ML, Sarasquete ME, del Pino-Montes J, Gaarder PI, Gonzalez M, Orfao A.
    Br J Haematol; 2006 Oct 01; 135(1):43-51. PubMed ID: 16939497
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.